Cargando…
Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
INTRODUCTION: Chagas disease remains a major cause of mortality in several countries of Latin America and has become a potential public health problem in non-endemic countries as a result of migration flows. Cardiac involvement represents the main cause of mortality, but its diagnosis is still based...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943653/ https://www.ncbi.nlm.nih.gov/pubmed/20877635 http://dx.doi.org/10.1371/journal.pntd.0000826 |
_version_ | 1782187039407472640 |
---|---|
author | Garcia-Alvarez, Ana Sitges, Marta Pinazo, María-Jesús Regueiro-Cueva, Ander Posada, Elizabeth Poyatos, Silvia Ortiz-Pérez, José Tomás Heras, Magda Azqueta, Manel Gascon, Joaquim Sanz, Ginés |
author_facet | Garcia-Alvarez, Ana Sitges, Marta Pinazo, María-Jesús Regueiro-Cueva, Ander Posada, Elizabeth Poyatos, Silvia Ortiz-Pérez, José Tomás Heras, Magda Azqueta, Manel Gascon, Joaquim Sanz, Ginés |
author_sort | Garcia-Alvarez, Ana |
collection | PubMed |
description | INTRODUCTION: Chagas disease remains a major cause of mortality in several countries of Latin America and has become a potential public health problem in non-endemic countries as a result of migration flows. Cardiac involvement represents the main cause of mortality, but its diagnosis is still based on nonspecific criteria with poor sensitivity. Early identification of patients with cardiac involvement is desirable, since early treatment may improve prognosis. This study aimed to assess the role of diastolic dysfunction, abnormal myocardial strain and elevated brain natriuretic peptide (BNP) in the early identification of cardiac involvement in Chagas disease. METHODOLOGY/PRINCIPAL FINDINGS: Fifty-four patients divided into 3 groups—group 1 (undetermined form: positive serology without ECG or 2D-echocardiographic abnormalities; N = 32), group 2 (typical ECG abnormalities of Chagas disease but normal 2D-echocardiography; N = 14), and group 3 (regional wall motion abnormalities, left ventricular [LV] end-diastolic diameter >55 mm or LV ejection fraction <50% on echocardiography; N = 8)—and 44 control subjects were studied. Patients with significant non-cardiac diseases, other heart diseases and previous treatment with benznidazol were excluded. The median age was 37 (20–58) years; 40% were men. BNP levels, longitudinal and radial myocardial strain and LV diastolic dysfunction increased progressively from group 1 to 3 (p for trend <0.01). Abnormal BNP levels (>37 pg/ml) were noted in 0%, 13%, 29% and 63% in controls and groups 1 to 3, respectively. Half of patients in the undetermined form had impaired relaxation patterns, whereas half of patients with ECG abnormalities suggestive of Chagas cardiomyopathy had normal diastolic function. In group 1, BNP levels were statistically higher in patients with diastolic dysfunction as compared to those with normal diastolic function (27±26 vs. 11±8 pg/ml, p = 0.03). CONCLUSION/SIGNIFICANCE: In conclusion, the combination of diastolic function and BNP measurement adds important information that could help to better stratify patients with Chagas disease. |
format | Text |
id | pubmed-2943653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-29436532010-09-28 Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage Garcia-Alvarez, Ana Sitges, Marta Pinazo, María-Jesús Regueiro-Cueva, Ander Posada, Elizabeth Poyatos, Silvia Ortiz-Pérez, José Tomás Heras, Magda Azqueta, Manel Gascon, Joaquim Sanz, Ginés PLoS Negl Trop Dis Research Article INTRODUCTION: Chagas disease remains a major cause of mortality in several countries of Latin America and has become a potential public health problem in non-endemic countries as a result of migration flows. Cardiac involvement represents the main cause of mortality, but its diagnosis is still based on nonspecific criteria with poor sensitivity. Early identification of patients with cardiac involvement is desirable, since early treatment may improve prognosis. This study aimed to assess the role of diastolic dysfunction, abnormal myocardial strain and elevated brain natriuretic peptide (BNP) in the early identification of cardiac involvement in Chagas disease. METHODOLOGY/PRINCIPAL FINDINGS: Fifty-four patients divided into 3 groups—group 1 (undetermined form: positive serology without ECG or 2D-echocardiographic abnormalities; N = 32), group 2 (typical ECG abnormalities of Chagas disease but normal 2D-echocardiography; N = 14), and group 3 (regional wall motion abnormalities, left ventricular [LV] end-diastolic diameter >55 mm or LV ejection fraction <50% on echocardiography; N = 8)—and 44 control subjects were studied. Patients with significant non-cardiac diseases, other heart diseases and previous treatment with benznidazol were excluded. The median age was 37 (20–58) years; 40% were men. BNP levels, longitudinal and radial myocardial strain and LV diastolic dysfunction increased progressively from group 1 to 3 (p for trend <0.01). Abnormal BNP levels (>37 pg/ml) were noted in 0%, 13%, 29% and 63% in controls and groups 1 to 3, respectively. Half of patients in the undetermined form had impaired relaxation patterns, whereas half of patients with ECG abnormalities suggestive of Chagas cardiomyopathy had normal diastolic function. In group 1, BNP levels were statistically higher in patients with diastolic dysfunction as compared to those with normal diastolic function (27±26 vs. 11±8 pg/ml, p = 0.03). CONCLUSION/SIGNIFICANCE: In conclusion, the combination of diastolic function and BNP measurement adds important information that could help to better stratify patients with Chagas disease. Public Library of Science 2010-09-21 /pmc/articles/PMC2943653/ /pubmed/20877635 http://dx.doi.org/10.1371/journal.pntd.0000826 Text en Garcia-Alvarez et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Garcia-Alvarez, Ana Sitges, Marta Pinazo, María-Jesús Regueiro-Cueva, Ander Posada, Elizabeth Poyatos, Silvia Ortiz-Pérez, José Tomás Heras, Magda Azqueta, Manel Gascon, Joaquim Sanz, Ginés Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage |
title | Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and
Brain Natriuretic Peptide in the Early Identification of Cardiac Damage |
title_full | Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and
Brain Natriuretic Peptide in the Early Identification of Cardiac Damage |
title_fullStr | Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and
Brain Natriuretic Peptide in the Early Identification of Cardiac Damage |
title_full_unstemmed | Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and
Brain Natriuretic Peptide in the Early Identification of Cardiac Damage |
title_short | Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and
Brain Natriuretic Peptide in the Early Identification of Cardiac Damage |
title_sort | chagas cardiomiopathy: the potential of diastolic dysfunction and
brain natriuretic peptide in the early identification of cardiac damage |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943653/ https://www.ncbi.nlm.nih.gov/pubmed/20877635 http://dx.doi.org/10.1371/journal.pntd.0000826 |
work_keys_str_mv | AT garciaalvarezana chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage AT sitgesmarta chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage AT pinazomariajesus chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage AT regueirocuevaander chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage AT posadaelizabeth chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage AT poyatossilvia chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage AT ortizperezjosetomas chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage AT herasmagda chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage AT azquetamanel chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage AT gasconjoaquim chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage AT sanzgines chagascardiomiopathythepotentialofdiastolicdysfunctionandbrainnatriureticpeptideintheearlyidentificationofcardiacdamage |